<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02293486</url>
  </required_header>
  <id_info>
    <org_study_id>GRA 01</org_study_id>
    <nct_id>NCT02293486</nct_id>
  </id_info>
  <brief_title>Study of Pomegranate Juice in the Modulation of Oxidative Stress Markers in Endurance-based Athletes</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Miguel Hernandez de Elche</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vitalgrana Pomegranate SL</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Miguel Hernandez de Elche</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate modifications of plasma protein carbonyls and
      malondialdehyde levels in endurance-based athletes after three weeks of pomegranate juice
      consumption.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">February 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Protein carbonyls levels changes in plasma</measure>
    <time_frame>day 0 and 22</time_frame>
    <description>Protein carbonyl derivatives were determined using an adaptation of the colorimetric method published in Levine et al. (1994) based in the formation of a stable 2,4-dinitrophenyl (DNP) hydrazone product after the addition of 2,4-dinitrophenylhydrazine (DNPH) to tha plasma. Protein carbonyls were calculated as nmoles·mg-1 protein</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Malondialdehyde levels changes in plasma</measure>
    <time_frame>day 0 and 22</time_frame>
    <description>Malondialdehyde was determined by high pressure liquid chromatography (HPLC) with fluorescence detection according to the method described by Laporta et al. (2007). Malondialdehyde levels were calculated as nmoles·g-1 protein</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood biochemical parameters changes in plasma</measure>
    <time_frame>day 0 and 22</time_frame>
    <description>Blood biochemical parameters is a composite outcome measure consisting in circulating plasma glucose (mg·dL-1), HDL-cholesterol (mg·dL-1), triglycerides (mg·dL-1), ferritin (ng·mL-1), lactate (mg·dL-1), sodium (mEq·L-1), potassium (mEq·L-1), creatine kinase (U·L-1), aspartate aminotransferase (U·L-1) and alanine aminotransferase (U·L-1) were analyzed through biochemistry methods.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein levels changes in plasma</measure>
    <time_frame>day 0 and 22</time_frame>
    <description>Determination by immunoassay of C-reactive protein (ng·mL-1) levels in plasma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Soluble E-selectin levels changes in plasma</measure>
    <time_frame>day 0 and 22</time_frame>
    <description>Determination by immunoassay of soluble E-selectin (ng·mL-1) levels in plasma.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Arm that followed all the protocols with the exception of the pomegranate juice intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pomegranate Juice</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm that followed all the protocols and the pomegranate juice intake.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pomegranate Juice Dilution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Arm that followed all the protocols and the pomegranate juice dilution (1:1) intake.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Pomegranate juice</intervention_name>
    <description>Intake of 200 ml of pomegranate juice or pomegranate juice dilution during 21 days after exercise.</description>
    <arm_group_label>Pomegranate Juice</arm_group_label>
    <arm_group_label>Pomegranate Juice Dilution</arm_group_label>
    <other_name>Zumo de Granada Vitalgrana</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Perform specific endurance training sessions

          -  More than 1 hour per session and more than 3 sessions per week

          -  Have participated recently in a half marathon or similar event

        Exclusion Criteria:

          -  Intake of antioxidant or anti-inflammatory supplementation

          -  Present a chronic disorder

          -  Non-smoker

          -  No-alcoholic beverage consumption
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrique Roche, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Miguel Hernández</affiliation>
  </overall_official>
  <results_reference>
    <citation>Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr. 2000 May;71(5):1062-76.</citation>
    <PMID>10799367</PMID>
  </results_reference>
  <results_reference>
    <citation>Trombold JR, Reinfeld AS, Casler JR, Coyle EF. The effect of pomegranate juice supplementation on strength and soreness after eccentric exercise. J Strength Cond Res. 2011 Jul;25(7):1782-8. doi: 10.1519/JSC.0b013e318220d992.</citation>
    <PMID>21659887</PMID>
  </results_reference>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>November 13, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2014</study_first_posted>
  <last_update_submitted>November 13, 2014</last_update_submitted>
  <last_update_submitted_qc>November 13, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Miguel Hernandez de Elche</investigator_affiliation>
    <investigator_full_name>Néstor Vicente-Salar</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Antioxidants</keyword>
  <keyword>Protein Carbonylation</keyword>
  <keyword>Malondialdehyde</keyword>
  <keyword>Punicaceae</keyword>
  <keyword>Athletic Performance</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

